Sponsored
Emcure stake buy: Pharma firm to acquire 20.42% in Zuventus for Rs 724.9 crore; full ownership to aid consolidation
Posted
Emcure Pharmaceuticals will acquire the remaining 20.42% stake in Zuventus Healthcare for ₹724.9 crore, making it a wholly-owned subsidiary. The board has approved the acquisition from minority shareholders, with the transaction expected to close in the September quarter of FY26.
Search
Categories
- National
- International
- Business
- Technology
- Health
- Education
- Sports
- Entertainment
- Travel
- Environment
- Science
- Law
- Agriculture
- Real Estate
- Opinion
- Religion
- Weather
- Automotive
- Social Issues
- Culture
- Sci-Fi & Future
Read More
Ranjita assigns Shiva Bastola as NUP’s Acting President
KATHMANDU: Shiva Bastola has been appointed as the Acting President of the Nagarik Unmukti Party...
‘Disruptive behaviour’: Did French authorities remove Jewish passengers from Paris-bound plane? What airlines said
French authorities are investigating the removal of a group of young French citizens, members of...
Russia starts direct flights to North Korea
Russia has initiated direct commercial flights to North Korea, signaling strengthened ties amidst...
Watch: Chahal’s first-ever b'day surprise by RJ Mahvash
Yuzvendra Chahal's 35th birthday in London turned into a heartwarming surprise orchestrated by RJ...
'Just like Ponting in 2005'– Karthik backs Gill to lead India’s charge at Old Trafford
Dinesh Karthik lauded Shubman Gill's resilient performance in the fourth Test, drawing parallels...